Paper41007243
Rapamycin Mitigates Corneal Damage in a Mouse Model of Alkali Burn Injury.
Bhujel B and 5 others. Bioengineering (Basel), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Rapamycin Mitigates Corneal Damage in a Mouse Model of Alkali Burn Injury. Papers, record 41007243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NRF-2022R1F1A1073895, 2025IL0022 | Basic Science Research Program through the National Research Foundation of Korea (NRF), Asan Institute for Life Sciences, Seoul, Republic of Korea. | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28106169 | Inhibition of NUCKS Facilitates Corneal Recovery Following Alkali Burn. | Sci Rep | 2017 | https://conductscience.org/library/papers/28106169 | PubMed |
| 2 | 40140459 | Irradiated umbilical cord mesenchymal stem cell-coated high oxygen-permeable hydrogel lenses inhibit corneal inflammation and neovascularization after corneal alkali burns. | Sci Rep | 2025 | https://conductscience.org/library/papers/40140459 | PubMed |
| 3 | 39172123 | Inhibition of Experimental Corneal Neovascularization by the Tight Junction Protein ZO-1. | J Ocul Pharmacol Ther | 2024 | https://conductscience.org/library/papers/39172123 | PubMed |
| 4 | 37068601 | The role of KS GAGs in the microstructure of CXL-treated corneal stroma; a transmission electron microscopy study. | Exp Eye Res | 2023 | https://conductscience.org/library/papers/37068601 | PubMed |
| 5 | 37174694 | Pathogenesis of Alkali Injury-Induced Limbal Stem Cell Deficiency: A Literature Survey of Animal Models. | Cells | 2023 | https://conductscience.org/library/papers/37174694 | PubMed |
| 6 | 22323486 | Netrin-1 simultaneously suppresses corneal inflammation and neovascularization. | Invest Ophthalmol Vis Sci | 2012 | https://conductscience.org/library/papers/22323486 | PubMed |
| 7 | 30114412 | Differential expression of corneal and limbal cytokines and chemokines throughout the clinical course of sulfur mustard induced ocular injury in the rabbit model. | Exp Eye Res | 2018 | https://conductscience.org/library/papers/30114412 | PubMed |
| 8 | 22898649 | Corneal neovascularization: an anti-VEGF therapy review. | Surv Ophthalmol | 2012 | https://conductscience.org/library/papers/22898649 | PubMed |
| 9 | 37012439 | Effect of adalimumab on experimental corneal neovascularization model. | Int Ophthalmol | 2023 | https://conductscience.org/library/papers/37012439 | PubMed |
| 10 | 38660397 | Conditional deletion of Zeb1 in Csf1r+ cells reduces inflammatory response of the cornea to alkali burn. | iScience | 2024 | https://conductscience.org/library/papers/38660397 | PubMed |
| 11 | 39294598 | Long-term outcomes in rapamycin on renal allograft function: a 30-year follow-up from a single-center experience. | BMC Nephrol | 2024 | https://conductscience.org/library/papers/39294598 | PubMed |
| 12 | 38582513 | Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38582513 | PubMed |
| 13 | 11135052 | Rapamycin in transplantation: a review of the evidence. | Kidney Int | 2001 | https://conductscience.org/library/papers/11135052 | PubMed |
| 14 | 28054657 | Rapamycin Prolongs the Survival of Corneal Epithelial Cells in Culture. | Sci Rep | 2017 | https://conductscience.org/library/papers/28054657 | PubMed |
| 15 | 27329698 | MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea. | Sci Rep | 2016 | https://conductscience.org/library/papers/27329698 | PubMed |
| 16 | 24194635 | An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model. | Mol Vis | 2013 | https://conductscience.org/library/papers/24194635 | PubMed |
| 17 | 28501766 | Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model. | Int Immunopharmacol | 2017 | https://conductscience.org/library/papers/28501766 | PubMed |
| 18 | 23716625 | Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23716625 | PubMed |
| 19 | 37590514 | Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model. | J Vis Exp | 2023 | https://conductscience.org/library/papers/37590514 | PubMed |
| 20 | 23615260 | Accelerating repaired basement membrane after bevacizumab treatment on alkali-burned mouse cornea. | BMB Rep | 2013 | https://conductscience.org/library/papers/23615260 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930058 | Gene Therapy for Corneal Diseases. | BioTech (Basel) | 2026 | https://conductscience.org/library/papers/42930058 | PubMed |
| 42502695 | The association study between MTOR and high myopia. | Adv Ophthalmol Pract Res | 2026 | https://conductscience.org/library/papers/42502695 | PubMed |
| 42074327 | Therapeutic Efficacy of Rapamycin in an Experimental Mouse Model of Corneal Alkali Burn. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074327 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007243
GET https://conductscience.org/api/papers/v1/41007243/references?page=2